Alar Pharmaceuticals (ROCO:6785) Institutional Ownership: 0.07% (As of Aug. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6785 Alar Pharmaceuticals Inc ROCO:6785
51 GF Score
Price NT$100.00
GF Value NT$97.12
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Alar Pharmaceuticals Institutional Ownership?

Alar Pharmaceuticals ROCO:6785 51 Institutional Ownership is 0.07% as of Aug. 15, 2026. GuruFocus rates ROCO:6785 with a GF Score™ of 51/100 and a GF Value™ of NT$97.12 (Fairly Valued). The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Alar Pharmaceuticals's institutional ownership is 0.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Alar Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Alar Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

Alar Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Alar Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alar Pharmaceuticals Institutional Ownership Chart

Alar Pharmaceuticals Historical Data

The historical data trend for Alar Pharmaceuticals can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 0.04 0.04 0.11 0.11 0.04 0.04 0.04 0.04 0.07 0.07
ROCO:6785
51GF Score
Alar Pharmaceuticals Inc ROCO:6785
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alar Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 0.07% mean?
Alar Pharmaceuticals (ROCO:6785) has a Institutional Ownership of 0.07% as of Aug. 15, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Alar Pharmaceuticals and its competitors.
Is Alar Pharmaceuticals' Institutional Ownership too high?
Alar Pharmaceuticals' current Institutional Ownership is 0.07%. Overall, Alar Pharmaceuticals has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Alar Pharmaceuticals' Institutional Ownership compare to ZTS?
Alar Pharmaceuticals' Institutional Ownership of 0.07% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Alar Pharmaceuticals and its competitors. Alar Pharmaceuticals's current Institutional Ownership is 0.07%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alar Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Alar Pharmaceuticals (ROCO:6785) is currently considered Fairly Valued. The stock's GF Value™ is NT$97.12, compared to a current price of NT$100.00 — trading 3% above its estimated fair value. The current Institutional Ownership is 0.07%. Alar Pharmaceuticals' overall GF Score™ is 51/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Alar Pharmaceuticals (ROCO:6785), the current Institutional Ownership is 0.07% as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alar Pharmaceuticals (ROCO:6785) Overvalued in 2026?

Based on GuruFocus' analysis, Alar Pharmaceuticals stock appears to be overvalued. The current stock price of NT$100.00 is trading 3% above its estimated GF Value™ of NT$97.12. GuruFocus considers Alar Pharmaceuticals to be Fairly Valued.

Key valuation signals for ROCO:6785:

  • Institutional Ownership: 0.07%
  • GF Value™: NT$97.12 vs. price of NT$100.00 (3% above fair value)
  • GF Score™: 51/100 with 2 warning signs

No single metric tells the full story. See the ROCO:6785 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alar Pharmaceuticals Business Description

Address Jhongke Road, No. 32, No. 2, 5th Floor, Situn District, Taichung, TWN, 428015
Alar Pharmaceuticals Inc is a drug development company mainly engaged in the research and development of new drugs, sales of western pharmaceuticals, and medical devices. It focuses on developing long-acting release drug products for CNS disorders and chronic diseases, which mainly include opioid use disorder, chronic pain, and depressive disorder. The company currently has only a new drug development division, and its product pipeline comprises various drug candidates such as ALA-1000 (Buprenorphine), ALA-1300, ALA-2000 (Naltrexone), ALA-3000 (Ketamine), ALA-4000 (Apomorphine), and ALA-5000 (Third-generation antipsychotic). Geographically, the company generates maximum revenue from the USA and also has its presence in Taiwan and the United Kingdom.
51GF Score

Get the complete analysis for ROCO:6785

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$100.00
Price
NT$97.12
GF Value